{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:40:02Z","timestamp":1739101202191,"version":"3.37.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/bf03040422","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T17:49:38Z","timestamp":1242150578000},"page":"37-41","source":"Crossref","is-referenced-by-count":4,"title":["Bone metabolism during interferon-alpha treatment of essential thrombocythemia","Einfluss der Therapie mit Interferon-alpha auf den Knochenstoffwechsel bei der essentiellen Thrombozyth\u00e4mie"],"prefix":"10.1007","volume":"116","author":[{"given":"Rajko","family":"Kusec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Kusec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Gisslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Woloszczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Gisslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03040422_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2141.1993.tb04631.x","volume":"83","author":"JT Reilly","year":"1993","unstructured":"Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A (1993) Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis. Br J Heamatology 83: 58\u201362","journal-title":"Br J Heamatology"},{"key":"BF03040422_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0140-6736(89)92142-9","volume":"8639","author":"H Gisslinger","year":"1989","unstructured":"Gisslinger H, Ludwig H, Linkesch W, Chott A, Fritz E, Radaszkiewicz T (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet 8639: 634\u2013637","journal-title":"Lancet"},{"issue":"[Suppl 1]","key":"BF03040422_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2141.1991.tb08118.x","volume":"79","author":"H Gisslinger","year":"1991","unstructured":"Gisslinger H, Chott A, Scheithauer W, Gilly B, Linkesch W, Ludwig H (1991) Interferon in essential thrombocythemia. Br J Hematol 79 [Suppl 1]: 42\u201347","journal-title":"Br J Hematol"},{"key":"BF03040422_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1600-0609.1992.tb01790.x","volume":"48","author":"H Kasparu","year":"1992","unstructured":"Kasparu H, Bernhart M, Krieger O, Lutz D (1992) Remission may continue after termination of IFN alpha-2b treatment for essential thrombocythemia. Eur J Hematol 48: 33\u201336","journal-title":"Eur J Hematol"},{"key":"BF03040422_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF01738473","volume":"66","author":"S Sacchi","year":"1993","unstructured":"Sacchi S, Tabilio A, Leoni P, Riccardi A, Vecchi A, Messora C, et al (1993) Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term \u03b1-IFN treatment. Ann Hematol 66: 245\u2013246","journal-title":"Ann Hematol"},{"key":"BF03040422_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.leu.2400931","volume":"12","author":"S Sacchi","year":"1998","unstructured":"Sacchi S, Kantarjian HM, Smith TL, O\u2019Brien S, Pierce S, Kornblau S, et al (1998) Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ET. Leukemia 12: 289\u2013294","journal-title":"Leukemia"},{"key":"BF03040422_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO;2-8","volume":"83","author":"HS Gilbert","year":"1998","unstructured":"Gilbert HS (1998) Long-term treatment of myeloproliferative disease with Interferon alpha-2b. Cancer 83: 1205\u20131213","journal-title":"Cancer"},{"key":"BF03040422_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000126396","volume":"57","author":"H Gisslinger","year":"1993","unstructured":"Gisslinger H, Svoboda T, Clodi M, Gilly B, Ludwig H, Havelec L, et al (1993) Interferon-alpha stimulates the hypothalamic-pituitary adrenal axis in vivo and in vitro. Neuroendocrinology 57: 489\u2013495","journal-title":"Neuroendocrinology"},{"key":"BF03040422_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1172\/JCI111480","volume":"74","author":"SA Jimenez","year":"1984","unstructured":"Jimenez SA, Freundlich B, Rosenbloom J (1984) Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 74: 1112\u20131116","journal-title":"J Clin Invest"},{"key":"BF03040422_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1432-1033.1990.tb19377.x","volume":"193","author":"JN Beresford","year":"1990","unstructured":"Beresford JN, Taylor GT, Triffitt JT (1990) Interferons and bone. A comparison of the effects of interferon-\u03b1 and interferon-\u03bb in cultures of human bone-derived cells and an osteosarcoma cell line. Eur J Biochem 193: 589\u2013597","journal-title":"Eur J Biochem"},{"key":"BF03040422_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<372::AID-JCB6>3.0.CO;2-H","volume":"74","author":"RO Oreffo","year":"1999","unstructured":"Oreffo RO, Romberg S, Virdi AS, Joyner CJ, Berven S, Triffitt JT (1999) Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro. J Cell Biochem 74: 372\u2013385","journal-title":"J Cell Biochem"},{"key":"BF03040422_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000213041","volume":"35","author":"S Shiozawa","year":"1989","unstructured":"Shiozawa S, Tanaka Y, Morimoto I, Miyauchi A, Yammatani T, Fujita T (1989) Radioimmunoassay of circulating alpha-interferon with reference to aging and osteoporosis. Gerontology 35: 305\u2013310","journal-title":"Gerontology"},{"key":"BF03040422_CR13","first-page":"28","volume":"36","author":"MPM Herrmann-Erlee","year":"1984","unstructured":"Herrmann-Erlee MPM, Mulders M, van der Meer JM, van Zeeland JK, Loewi CWCM (1984) The effects of rat interferon on bone resorption and on the growth and differentiation of normal and transformed bone cells. Calc Tiss Int 36: S28","journal-title":"Calc Tiss Int"},{"key":"BF03040422_CR14","first-page":"9","volume":"1","author":"RH Christenson","year":"1997","unstructured":"Christenson RH (1997) Biochemical markers of bone metabolism: an overview. Drugs Aging [Suppl 1]: 9\u201314","journal-title":"Drugs Aging"},{"key":"BF03040422_CR15","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood.V84.12.4142.bloodjournal84124142","volume":"84","author":"MJ Aman","year":"1994","unstructured":"Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C (1994) Regulation of cytokine expression by interferon-\u03b1 in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 84: 4142\u20134150","journal-title":"Blood"},{"key":"BF03040422_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S8756-3282(99)00182-9","volume":"25","author":"GR Goodman","year":"1999","unstructured":"Goodman GR, Dissanayake IR, Gorodetsky E, Zhou H, Ma YF, Jee WSS, et al (1999) Interferon \u03b1 unlike interferon \u03bb, does not cause bone loss in the rat. Bone 25:459\u2013463","journal-title":"Bone"},{"issue":"[Suppl 1]","key":"BF03040422_CR17","first-page":"201","volume":"10","author":"T Miki","year":"1995","unstructured":"Miki T, Yoshida H, Nakatsuka K (1995) Effect of interferon-\u03b1 on bone metabolism and bone mineral density. J Bone Miner Res 10 [Suppl 1]: S201","journal-title":"J Bone Miner Res"},{"key":"BF03040422_CR18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.33588\/rn.3610.2002555","volume":"36","author":"JL Perez Castrillon","year":"2003","unstructured":"Perez Castrillon JL, Cano-Del Pozo M, Sanz-Izquierdo S, Velayos-Jimenez J, Dib-Wobakin W (2003) Bone mineral density in patients with multiple sclerosis: the effects of interferon. Rev Neurol 36: 901\u2013903","journal-title":"Rev Neurol"},{"issue":"[Suppl 227]","key":"BF03040422_CR19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/00365519709168304","volume":"57","author":"LM Demers","year":"1997","unstructured":"Demers LM (1997) Clinical usefulness of markers of bone degradation and formation. Scand. J Clin Lab Invest 57 [Suppl 227]: 12\u201320","journal-title":"J Clin Lab Invest"},{"key":"BF03040422_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1055\/s-2007-979007","volume":"29","author":"RGG Russel","year":"1997","unstructured":"Russel RGG (1997) The assessment of bone metabolism in vivo using biochemical approaches. Horm Metab Res 29: 138\u2013144","journal-title":"Horm Metab Res"},{"key":"BF03040422_CR21","first-page":"326","volume":"110","author":"R Smalcelj","year":"1998","unstructured":"Smalcelj R, Kusec V, Puretic Z, Marekovic Z (1998) Biochemical parameters of bone turnover in kidney transplant recipients. Wien Klin Wochenschr 110: 326\u2013330","journal-title":"Wien Klin Wochenschr"},{"key":"BF03040422_CR22","first-page":"277","volume":"44","author":"V Kusec","year":"1998","unstructured":"Kusec V, Kramaric M, Baric I, Stavljenic Rukavina A (1998) Osteocalcin and other serum bone biochemical markers in healthy population. Clinical Laboratory 44: 277\u2013283","journal-title":"Clinical Laboratory"},{"key":"BF03040422_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2257.2000.00269.x","volume":"22","author":"M Kauppila","year":"2000","unstructured":"Kauppila M, Koskinen P, Pulkki K, Sonninen P, Remes K, Irjala K, et al (2000) Interferon-\u03b1 treatment decreases serum cross-linked C-terminal Telopeptide of type I collagen in hematological diseases. Clin Lab Hem 22: 15\u201319","journal-title":"Clin Lab Hem"},{"key":"BF03040422_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1699-0463.1998.tb01377.x","volume":"106","author":"LW Pousen","year":"1998","unstructured":"Pousen LW, Melsen F, Bendix K (1998) A histomorphometric study of hematological disorders with respect to marrow fibrosis and osteosclerosis. APMIS 106: 495\u2013499","journal-title":"APMIS"},{"issue":"[Suppl 1]","key":"BF03040422_CR25","first-page":"138","volume":"10","author":"E Futami","year":"1995","unstructured":"Futami E, Shioi A, Jono S, Inaba M, Nishizawa Y, Morii H (1995) Interferon-\u03b1 can modulate the expression of parathyroid hormone receptor in human osteoblast-like cells. J Bone Miner Res 10 [Suppl 1]: S138","journal-title":"J Bone Miner Res"}],"container-title":["Wiener Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03040422\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:03:49Z","timestamp":1739099029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03040422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF03040422"],"URL":"https:\/\/doi.org\/10.1007\/bf03040422","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}